{"name": "setiptiline", "category": "drug", "content": "Setiptiline (brand name Tecipul), also known as teciptiline, is a tetracyclic antidepressant (TeCA) that acts as a noradrenergic and specific serotonergic antidepressant (NaSSA). It was launched in 1989 for the treatment of depression in Japan by Mochida.   == Pharmacology ==   === Pharmacodynamics ===  Setiptiline acts as a norepinephrine reuptake inhibitor, \u03b12-adrenergic receptor antagonist, and serotonin receptor antagonist, likely at the 5-HT2 subtypes, as well as an H1 receptor inverse agonist/antihistamine.   == Chemistry == Setiptiline has a tetracyclic structure and is a close analogue of mianserin and mirtazapine, with setiptiline being delta(13b,4a),4a-carba-mianserin, and mirtazapine being 6-azamianserin.   == See also == Aptazapine Mianserin Mirtazapine   == References =="}